GlassScriptPhysician profile
Logan Horejsi
NPI 1689304024
$4,053.36
in general payments reported to CMS, 2019-2025
18 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $366 · 2023: $1,116 · 2024: $1,326 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,606 · Education: $81.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,605.95 |
| Education | $81.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,330.20 | 2022-2025 | |
| Genzyme Corporation | $476.66 | 2022-2025 | |
| Arcutis Biotherapeutics, INC. | $423.75 | 2023-2025 | Zoryve |
| Ucb, INC. | $287.80 | 2024-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $233.34 | 2023-2025 | Nemluvio |
| Incyte Corporation | $208.65 | 2022-2025 | Opzelura |
| Pfizer INC. | $188.25 | 2024-2025 | |
| Lilly USA, LLC | $143.48 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Revance Therapeutics, INC. | $135.52 | 2024 | Daxxify |
| Amgen INC. | $124.49 | 2023-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $94.49 | 2024-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $90.25 | 2022-2025 | |
| Leo Pharma INC. | $78.50 | 2025 | Anzupgo |
| Sanofi-Aventis U.S. LLC | $72.00 | 2023 | |
| Sun Pharmaceutical Industries INC. | $69.40 | 2023 | Winlevi, Absorica Ld |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $48.18 | 2025 | Tremfya |
| Kowa Pharmaceuticals America, INC. | $33.90 | 2025 | Zoryve |
| Verrica Pharmaceuticals INC. | $14.50 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Horejsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.